Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensified Dosing of Cellcept in Kidney Transplantation Trial

NCT00943228 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT00943228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00943228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensified Dosing of Cellcept in Kidney Transplantation Trial
Lead sponsor
Nova Scotia Health Authority
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2010
Completion date
February 29, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute rejection of renal transplant